期刊文献+

骨髓增生异常综合征患者骨髓间充质干细胞细胞遗传学异常的研究 被引量:3

Cytogenetic Abnormalities in Bone Marrow Mesenchymal Stem Cells from Patients with Myelodysplastic Syndrome
暂未订购
导出
摘要 本研究旨在探讨骨髓增生异常综合征(MDS)患者与正常对照者造血细胞(HC)及经分离所得骨髓间充质干细胞(BMMSC)的细胞遗传学特征,分析其是否同时受累并参于MDS的发病及进展。收集我院血液科收治初诊的22例MDS患者及7例体检者(正常对照)骨髓,建立贴壁培养体系,分离并体外扩增BMMSC。根据形态学特征及流式细胞仪检测的表面抗原进行鉴定,初步分析MDS患者的BMMSC的细胞特征。进一步对HC和BMMSC同时进行胰酶-Giemsa技术(GTG)显带,根据ISCN(2005)要求,进行核型分析,并比较两者间的细胞遗传学特征。结果表明,本研究组成功建立了体外培养分离扩增体系。经光学显微镜及流式细胞仪鉴定证实,MDS患者的BMMSC具有典型的细长纺锤形的形态学特征及表达CD29、CD73、CD90,不表达CD34、CD45非造血细胞的抗原特征。MDS患者BMMSC也存在细胞染色体畸变(64%),以染色体物质不平衡畸变多见,尤其是缺失较为多见(92%),其中克隆性缺失7例,占50%。研究发现有高比例的随机丢失,不排除是其遗传学不稳定性的特征。HC与BMMSC间没有出现完全一致的畸变类型,HC正常核型的MDS患者中有5例存在畸变(33%),畸变率显著低于HC异常核型患者(92%)。结论:MDS患者BMMSC存在细胞遗传学异常。染色体物质不平衡畸变可能是其遗传学不稳定的标记,非造血起源的BMMSC显示有别于HC的畸变类型,提示两者遗传易感性相似但不完全相同。研究BMMSC在MDS发病机制中的潜在作用,有助于我们进一步认识该疾病生物学特征,为MDS的诊断及治疗提供新的途径。 This study was aimed to investigate the cytogenetic characteristics of hematopoietic cells(HC) and bone marrow mesenchymal stoma cells(BMMSC) isolated from patients with myelodysplastic syndrome(MDS) and healthy individuals as normal controls,and to clarify whether HC and BMMSC are simultaneously involved and participate in pathogenesis and development of MDS.Both marrows of 22 newly diagnosd patients with MDS and 7 healthy individuals were collected;BMMSC were isolated and amplified by using established culture system,as well as were identified according to morphologic features and surface antigens detected by flow cytometry;the characteristics of BMMSC from MDS patients were analyzed;the BMMSC karyotyping analysis of MDS patients was performed by banding of HC and BMMSC with pancreatin-Giemsa technique(GTG) and in accordance with ISCN(2005) requirements;the cytogenetic charactaristics of HC and BMMSC were compared.The results showed that in vitro culture system for isolation and amplification was successfully established.The light microscopy and flow cytometry confirmed that BMMSC possessed characteristics showing long and thin splindle form and expressing CD29,CD73,CD90 antigens,and unexpressing CD34,CD45 antigens.In BMMSC of 14 MDS patients(64%),the cytogenetic abnormalities were found usually involving the loss of chromosomal material(92%),among which clonal loss was observed in 7 cases(50%).The detection indicated a random loss of chromosomal material in significant proportion of BMMSC.A high proportion of chromosomal material random loss may be a marker of chromosomal instability in BMMSC of MDS patients,the detection also showed that completely consistent aberration types did not exist between HC and BMMSC.The aberrations wereobserved in 3 cases of MDS with normal karyotype of HC,its aberration rate(33%)was obviously lower than that inMDS patients with abrromal karyotypes(92%).It is concluded that the cytogenetic abnormalities exist in BMMSC ofMDS patients,the unbalanced aberration of chromosomal materials may be a genetic instability marker of BMMSC.Thedifference of aberration types in BMMSC from HC sugests that genetic susceptibility of BMMSC and HC is similar,butno completely identical,which indicates the potential involvement of BMMSC in pathogenesis of MDS.Studing thispotential role of BMMSC can be helpful to further understanding of MDS biological characteristics and provide the newapproaches for diagnosis and therapy of MDS.
出处 《中国实验血液学杂志》 CAS CSCD 2011年第2期372-378,共7页 Journal of Experimental Hematology
基金 上海交通大学附属第六人民医院院级科研基金项目,编号11004
关键词 骨髓增生异常综合征 间充质干细胞 细胞遗传学 myelodysplastic syndrome mesenchymal stem cell cytogenetic aberration
  • 相关文献

参考文献28

  • 1Hofmann WK, de Vos S, Komor M, et al. Characterization of gene expression of CD34 + cells from normal and myelodysplastic bone marrow. Blood,2002 ; 100:3553 - 3560.
  • 2Betz BL, Hess JL. Acute myeloid leukemia diagnosis in the 21st century. Arch Pathol Lab Med, 2010; 134 : 1427 - 1433.
  • 3Look AT. Molecular pathogenesis of MDS. Hematology, 2005; 156 - 160.
  • 4Wang H, Wang X, Xu X, et al. Cytogenetic features and prognosis analysis in Chinese patients with myelodysplastic syndrome: a multicenter study. Ann Hematol, 2010 ;89:535 -544.
  • 5Yilmaz Z, Sahin FI, Kizilkilic E, et al. Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients. Clin Exp Med, 2005 ;5:55 -59.
  • 6Giagounidis AA, Germing U, Haase S, et al. Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del (5q) including band q31. Leukemia, 2004;18:113 - 119.
  • 7缪扣荣,仇海荣,王蓉,张苏江,钱思轩,范磊,乔纯,洪鸣,张建富,陈丽娟,徐卫,李建勇.急性髓系白血病染色体核型异常分析研究[J].中国实验血液学杂志,2009,17(1):8-11. 被引量:19
  • 8Tefferi A, Vardiman JW. Myelodysplastic syndromes. N Engl J Med, 2009 ;361:1872 - 1885.
  • 9Schoch C, Kern W, Schnittger S, et al. Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML. Leukemia,2004; 18,120 - 125.
  • 10Marcondes AM, Ramakrishnan A, Deeg HJ. Myeloid malignancies and the marrow mieroenvironment: some recent studies in patients with MDS. Curr Cancer Ther Rev, 2009;5:310 -314.

二级参考文献14

  • 1张翼鷟,达万明.骨髓增生异常综合征患者间充质干细胞的生物学特性及其支持造血的体外研究[J].中国实验血液学杂志,2005,13(5):839-842. 被引量:9
  • 2张翼鷟,Loic Fouillard,Alain Chapel,Morad Bensidhoum,Christelle Mazurier,Aish Nasef,Sandrine Bouchet,Manuel Lopez,Dominique Thierry,Norbert Cclaucle Gorin,达万明.源于近端股骨间充质干细胞免疫抑制作用的研究[J].中华医学杂志,2005,85(39):2780-2784. 被引量:11
  • 3张翼鷟,达万明.骨髓增生异常综合征患者间充质干细胞SDF-1基因的表达[J].中国实验血液学杂志,2006,14(2):281-284. 被引量:5
  • 4Elaine S, Harris N, Stein H. Pathology and genetics of tumors of haematopietic and lymphoid tissues. France: IARC Press International Agency for Research on Cancer (IARC)69008 Lyon, France. 2001:76.
  • 5Udayakumar AM, Pathare AV, Al-Kindi S, et al. Cytogenetic, morphological and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia. Cancer Genet Cytogenet, 2007;177: 89 - 94.
  • 6Mrozek K, Heerema NA, Bloomfield CD. Cytogenetics in acute leukemia. Blood Rev, 2004; 18:115 -156.
  • 7King ME, Rowe JM. Recent developments in acute myelogenous leukemia therapy. Oncologist, 2007 ; 12 ( Suppl 2 ) : 14 - 21.
  • 8Shaffer LG, Tommerup N. ISCN ( 2005 ). An International System for Human Cytogenetic Nomenclature. Switzerland: Karger Basel publication, 2005:55 - 83.
  • 9Onsten T, Girardi FM, Coelho GM, et al. Cytogenetic and morphological findings in 166 patients with de novo acute myeloid leukemia in southern. Brazil Cancer Genet Cytogenet, 2006 ; 170 : 167 - 170.
  • 10Klaus M, Haferlaeh T, Sehnittger S, et al. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1 and M2 : a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization. Cancer Genet Cytogenet, 2004; 155:47-56.

共引文献23

同被引文献52

  • 1张翼鷟,达万明.骨髓增生异常综合征患者间充质干细胞的生物学特性及其支持造血的体外研究[J].中国实验血液学杂志,2005,13(5):839-842. 被引量:9
  • 2Dazzi F,Ramasamy R,Glennie S, et al. The role of mesenchymal stem cells in haemopoiesis. Blood Rev,2006 ;20 ( 3 ) : 161 - 171.
  • 3Kastrinaki MC, Pontikoglou C, Klaus M, et al. Biologic characteristics of bone marrow mesenehymal stem cells in myelodysplastic syndromes. Curr Stem Cell Res Ther, 2011; 6 (2) :122 -130.
  • 4Blan O, Hofmann WK, Baldus CD, et al. Chromosomal aberra- tions in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia. Exp Hematol, 2007 ;35(2) :221 -229.
  • 5Blau O, Baldus CD, Hofmann WK, et al. Mesenchymal stromal cells of myelodysplasfic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts. Blood. 2011 : 118(20), 5583 -5592.
  • 6Lopez-ViUar O, Garcia JL, Sanchez-Guijo FM, et al. Both expanded and tmcultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome. Leukemia ,2009;23(4) :664 -672.
  • 7Klaus M, Stavroulaki E, Kastrinaki MC, et al. Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes. Stem Cells Dev, 2010 ; 19 (7) : 1043 - 1054.
  • 8Aanei CM, Flandrin P, Zuqun Eloae F, et al. Intrinsic growth deficiencies of mesenchymal stromal cells in myelodysplastic syndromes. Stem Cells Dev, 2012 ;21 (10) :1604 - 1615.
  • 9Borojevic R, Rcela RA, Rodarte RS, et al. Bone marrow stroma in childhood myelodysplastic syndrome: composition, ability to sustain hematopoiesis in vitro, and altered gene expression. Leuk Res,2004;28(8) :831 -844.
  • 10Raaijmakers MH, Mukherjee S, Guo S, et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature,2010 ;464 (7290) : 852 - 857.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部